Authors:
Benhamou, S
Voho, A
Bouchardy, C
Mitrunen, K
Dayer, P
Hirvonen, A
Citation: S. Benhamou et al., Role of NAD(P)H: quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers, BIOMARKERS, 6(6), 2001, pp. 440-447
Citation: P. Wanner et al., Geographical disparities in self-reported use of mammography and breast self-examination according to the Swiss Health Survey, ANN ONCOL, 12(4), 2001, pp. 573-574
Authors:
Hirvonen, A
Bouchardy, C
Mitrunen, K
Kataja, V
Eskelinen, M
Kosma, VM
Saarikoski, ST
Jourenkova, N
Anttila, S
Dayer, P
Uusitupa, M
Benhamou, S
Citation: A. Hirvonen et al., Polymorphic GSTs and cancer predisposition, CHEM-BIO IN, 133(1-3), 2001, pp. 75-80
Authors:
Bouchardy, C
Queneau, PE
Fioretta, G
Usel, M
Zellweger, M
Neyroud, I
Raymond, L
de Wolf, C
Sappino, AP
Citation: C. Bouchardy et al., Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice, BR J CANC, 85(9), 2001, pp. 1251-1257
Authors:
Laforest, L
Wikman, H
Benhamou, S
Saarikoski, ST
Bouchardy, C
Hirvonen, A
Dayer, P
Husgafvel-Pursiainen, K
Citation: L. Laforest et al., CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships, EUR J CANC, 36(14), 2000, pp. 1825-1832
Authors:
de Perrot, M
Licker, M
Bouchardy, C
Usel, M
Robert, J
Spiliopoulos, A
Citation: M. De Perrot et al., Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma, J THOR SURG, 119(1), 2000, pp. 21-26
Authors:
Bouchardy, C
Hirvonen, A
Coutelle, C
Ward, PJ
Dayer, P
Benhamou, S
Citation: C. Bouchardy et al., Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract, INT J CANC, 87(5), 2000, pp. 734-740
Authors:
Jourenkova-Mironova, N
Mitrunen, K
Bouchardy, C
Dayer, P
Benhamou, S
Hirvonen, A
Citation: N. Jourenkova-mironova et al., High-activity microsomal epoxide hydrolase genotypes and the risk of oral,pharynx, and larynx cancers, CANCER RES, 60(3), 2000, pp. 534-536
Authors:
Jourenkova-Mironova, N
Voho, A
Bouchardy, C
Wikman, H
Dayer, P
Benhamou, S
Hirvonen, A
Citation: N. Jourenkova-mironova et al., Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk, CANC EPID B, 8(2), 1999, pp. 185-188
Authors:
Jourenkova-Mironova, N
Wikman, H
Bouchardy, C
Mitrunen, K
Dayer, P
Benhamou, S
Hirvonen, A
Citation: N. Jourenkova-mironova et al., Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes insusceptibility to oral/pharyngeal and laryngeal cancers, PHARMACOGEN, 9(4), 1999, pp. 533-537
Authors:
Ibeanu, GC
Blaisdell, J
Ferguson, RJ
Ghanayem, BI
Brosen, K
Benhamou, S
Bouchardy, C
Wilkinson, GR
Dayer, P
Goldstein, JA
Citation: Gc. Ibeanu et al., A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin, J PHARM EXP, 290(2), 1999, pp. 635-640
Authors:
Jourenkova-Mironova, N
Voho, A
Bouchardy, C
Wikman, H
Dayer, P
Benhamou, S
Hirvonen, A
Citation: N. Jourenkova-mironova et al., Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers, INT J CANC, 81(1), 1999, pp. 44-48
Authors:
Bouchardy, C
Fioretta, G
De Perrot, M
Obradovic, M
Spiliopoulos, A
Citation: C. Bouchardy et al., Determinants of long term survival after surgery for cancer of the lung - A population-based study, CANCER, 86(11), 1999, pp. 2229-2237
Authors:
Jourenkova-Mironova, N
Wikman, H
Bouchardy, C
Voho, A
Dayer, P
Benhamou, S
Hirvonen, A
Citation: N. Jourenkova-mironova et al., Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer, PHARMACOGEN, 8(6), 1998, pp. 495-502